Proteomic analysis at the bedside: early detection of cancer.

Emanuel F. Petricoin*, Lance A. Liotta

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

36 Scopus citations


Proteomic technologies promise to accelerate rapidly a new era in molecular medicine, especially in the detection and discovery of disease-related biomarkers. These technologies have no bigger impact than in the field of human cancer research. Beyond lifestyle-associated prevention strategies, early detection of cancer has the most profound impact on the ultimate course of the disease: the earlier the cancer is detected, the better the prognosis. Today, new proteomic technologies are being used to discover new diagnostic and prognostic biomarkers for the early detection and treatment of cancer that will have important implications at the bedside.

Original languageEnglish
Pages (from-to)S30-34
JournalTrends in biotechnology
Issue number12 Suppl
StatePublished - Dec 2002
Externally publishedYes


Dive into the research topics of 'Proteomic analysis at the bedside: early detection of cancer.'. Together they form a unique fingerprint.

Cite this